Joshua R. Disbrow
Overview
Joshua R. Disbrow received an average of $2M in total compensation, including $459K in salary, at AYTU BIOPHARMA from 2017 to 2023. Joshua Disbrow also received an average of $1M at Ampio Pharmaceuticals from 2012 to 2015.
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2015
- 2013
- 2012
AYTU BIOPHARMAChairman and Chief Executive Officer since December
AYTU BIOPHARMAChairman and Chief Executive Officer since December
AYTU BIOPHARMAChief Executive Officer since December
AYTU BIOPHARMAChief Executive Officer
AYTU BIOPHARMAChief Executive Officer since December
AYTU BIOPHARMAChief Executive Officer
AYTU BIOPHARMAChief Executive Officer
Ampio PharmaceuticalsFormer Chief Operating Officer and Chief Executive Officer of Aytu BioScience, Inc
Ampio PharmaceuticalsChief Operating Officer
Ampio PharmaceuticalsChief Operating Officer
Source: SEC filings on May 10, 2024, April 7, 2022, April 16, 2021, March 5, 2020, February 25, 2019, October 31, 2018, and August 15, 2014.
Related executives
We found 15 more executives who work or worked at AYTU BIOPHARMA and Ampio Pharmaceuticals.
Greg Pyszczymuka
AYTU BIOPHARMA
Chief Commercial Officer since January
Mark Oki
AYTU BIOPHARMA
Chief Financial Officer
David Green
AYTU BIOPHARMA
Chief Financial Officer
Richard Eisenstadt
AYTU BIOPHARMA
Chief Financial Officer
since Green
AYTU BIOPHARMA
Chief Financial Officer
Jarrett Disbrow
AYTU BIOPHARMA
Chief Operating Officer
since Disbrow
AYTU BIOPHARMA
Chief Operating Officer
since Gould
AYTU BIOPHARMA
Chief Financial Officer
News
AYTU BIOPHARMA CEO Joshua Disbrow's 2023 pay rises 20% to $708K
May 10, 2024
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2020 pay jumps 52% to $1.6M
April 16, 2021
AYTU BIOPHARMA CEO Joshua Disbrow's 2019 pay jumps 72% to $1M
March 5, 2020
AYTU BIOPHARMA CEO Joshua Disbrow's 2018 pay falls 42% to $606K
February 25, 2019